I love the AUA's annual meeting. Where else can you geek out on every topic from the latest in infertility treatment to neuromodulation, all while catching up with old friends and colleagues? If I was a urologic oncologist who specialized in distal one-third left-sided ureteral tumors, perhaps I'd find the Society of Urological Oncology's annual meeting more useful (and to be fair, I've attended the SUO meeting and it’s great, if a bit intense). But for a small-town urologist like me, you can't beat the AUA annual meeting.
After poring over this year’s program, I’ve identified 10 sessions and features of this year’s event that I don’t want to miss.
1. Online access. It’s not a single session, but this year I'm going to try something a bit different. As you may know, I have four girls under five and while my wife is truly incredible, I somehow doubt she would be thrilled if I left her alone with the kids for a week. Instead of attending the entire conference, I'll be flying in for the weekend and then taking advantage of some of the online tools available to follow the rest of the it. For example, the On-Demand Course Pass records and then posts on the web all courses within 48 hours. The AUA does the same for the plenary session so now there is no reason to miss a lecture! Also, I highly recommend the AUA meeting mobile app. While this year's version wasn’t available at this writing, last year’s app was a lifesaver, as this meeting is simply too busy to navigate without some help. You should be able to find this year's app by searching iTunes for AUA 2017.
More from Dr. Rosevear: Men’s health: A forgotten topic
2. New guidelines. While I concede that I often skip the actual presentations about clinical practice guidelines, I am always interested to know what guidelines are being introduced or updated. The guideline writers do their job so well (their work is always easy to read and has plenty of background material) that the actual presentation is sometimes redundant. I do always read any guidelines that the AUA releases. This year, I'm particularly excited about guidelines on localized prostate cancer (divided into low-, intermediate-, and high-risk disease) that will be presented at the Friday morning plenary.